Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | unspecified product | 0.0019 | 0.0436 | 0.1763 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.1763 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.1763 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0066 | 0.3904 | 1 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.0436 | 0.0576 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0016 | 0.0224 | 0.0906 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0047 | 0.2471 | 0.5869 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.3904 | 1 |
Mycobacterium tuberculosis | Probable reductase | 0.0106 | 0.6877 | 0.8837 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0016 | 0.0224 | 0.0906 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.1763 |
Echinococcus granulosus | dna polymerase kappa | 0.0019 | 0.0436 | 0.0576 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0016 | 0.0224 | 0.5 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0118 | 0.7753 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0106 | 0.6877 | 0.8837 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0118 | 0.7753 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0066 | 0.3904 | 0.3765 |
Brugia malayi | glutathione reductase | 0.0047 | 0.2471 | 0.6106 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.1763 |
Plasmodium vivax | glutathione reductase, putative | 0.0047 | 0.2471 | 1 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0019 | 0.0436 | 0.1763 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0019 | 0.0436 | 0.0217 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0118 | 0.7753 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0047 | 0.2471 | 0.5869 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0.0224 | 0.5 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0106 | 0.6877 | 0.8837 |
Echinococcus granulosus | dna polymerase eta | 0.0019 | 0.0436 | 0.0576 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0066 | 0.3904 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.0436 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0019 | 0.0436 | 0.0281 |
Echinococcus granulosus | carboxylesterase 5A | 0.0066 | 0.3904 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0047 | 0.2471 | 1 |
Toxoplasma gondii | thioredoxin reductase | 0.0047 | 0.2471 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0047 | 0.2471 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.3904 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0019 | 0.0436 | 0.0943 |
Echinococcus granulosus | acetylcholinesterase | 0.0066 | 0.3904 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.0943 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.0436 | 0.0576 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0016 | 0.0224 | 0.0906 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0436 | 0.1763 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0106 | 0.6877 | 0.8837 |
Loa Loa (eye worm) | carboxylesterase | 0.0066 | 0.3904 | 1 |
Echinococcus multilocularis | dna polymerase kappa | 0.0019 | 0.0436 | 0.0576 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.1763 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0019 | 0.0436 | 0.0943 |
Leishmania major | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.0943 |
Brugia malayi | Carboxylesterase family protein | 0.0066 | 0.3904 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0047 | 0.2471 | 1 |
Brugia malayi | Thioredoxin reductase | 0.0047 | 0.2471 | 0.6106 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.1763 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0019 | 0.0436 | 0.0943 |
Echinococcus multilocularis | dna polymerase eta | 0.0019 | 0.0436 | 0.0576 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0436 | 0.1763 |
Schistosoma mansoni | DNA polymerase eta | 0.0019 | 0.0436 | 0.0217 |
Leishmania major | trypanothione reductase | 0.0047 | 0.2471 | 1 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0019 | 0.0436 | 0.0281 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.0943 |
Echinococcus multilocularis | acetylcholinesterase | 0.0066 | 0.3904 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0047 | 0.2471 | 1 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0019 | 0.0436 | 0.0217 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.0436 | 0.0576 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.1763 |
Echinococcus multilocularis | acetylcholinesterase | 0.0066 | 0.3904 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0118 | 0.7753 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.0436 | 0.0576 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.1763 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0106 | 0.6877 | 0.8837 |
Brugia malayi | Carboxylesterase family protein | 0.0066 | 0.3904 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0047 | 0.2471 | 0.2985 |
Giardia lamblia | DINP protein human, muc B family | 0.0019 | 0.0436 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.0943 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.1763 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0047 | 0.2471 | 0.6106 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0019 | 0.0436 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0016 | 0.0224 | 0.0906 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0047 | 0.2471 | 0.6106 |
Echinococcus granulosus | acetylcholinesterase | 0.0066 | 0.3904 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.1763 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0019 | 0.0436 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.0436 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0106 | 0.6877 | 0.8837 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0436 | 0.0943 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0.0224 | 0.5 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0019 | 0.0436 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0436 | 0.1763 |
Treponema pallidum | NADH oxidase | 0.0016 | 0.0224 | 0.5 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0047 | 0.2471 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 25 ug ml-1 | Antibacterial activity against Escherichia coli ATCC 23556 after 24 hrs by serial dilution method | ChEMBL. | 17337097 |
MIC (functional) | = 25 ug ml-1 | Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hrs by serial dilution method | ChEMBL. | 17337097 |
MIC (functional) | = 25 ug ml-1 | Antifungal activity against Candida krusei ATCC 6258 after 48 hrs by serial dilution method | ChEMBL. | 17337097 |
MIC (functional) | = 25 ug ml-1 | Antifungal activity against Candida glabrata after 48 hrs by serial dilution method | ChEMBL. | 17337097 |
MIC (functional) | = 25 ug ml-1 | Antibacterial activity against Escherichia coli ATCC 23556 after 24 hrs by serial dilution method | ChEMBL. | 17337097 |
MIC (functional) | = 50 ug ml-1 | Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by serial dilution method | ChEMBL. | 17337097 |
MIC (functional) | = 50 ug ml-1 | Antifungal activity against Candida albicans after 48 hrs by serial dilution method | ChEMBL. | 17337097 |
MIC (functional) | = 50 ug ml-1 | Antifungal activity against Candida albicans after 48 hrs by serial dilution method | ChEMBL. | 17337097 |
MIC (functional) | = 200 ug ml-1 | Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by serial dilution method | ChEMBL. | 17337097 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.